SECreport

Form 4 Akoustis Technologies, For: Apr 01 Filed by: Shealy Jeffrey B.

Aktis Oncology, Inc. - Common stock  (AKTS) 
NASDAQ:AMEX Investor Relations: ir.akoustis.com